Disclaimer: This article was published in 2019 and reflects the information available at that time.
  Pharmacists breaching regulations involving opioid replacement therapy (ORT) are quickly referred to the regulators. A recent blitz from NSW Health against pharmacies that provide opioid-replacement services is resulting in members of PDL seeking support in handling regulator inquiries. Penalties such as restrictions on practice for pharmacy owners and employed pharmacists may be involved. These incidents highlight the importance of adhering to current State-based legislation when dealing with all S8 medications, including ORT products such as methadone syrup, Subu…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Professional Indemnity cover for pharmacy students
21 April 2026
NationalIncident managementRegulatory and compliancePractice support, tips and tools
Learn more
Communication matters
16 April 2026
NationalNSWLeadership and communicationIncident managementPractice support, tips and tools
Learn more
Professional Indemnity Insurance – what hospital pharmacists need to know
1 April 2026
National
Learn more